Market Cap

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Market Capitalization:

€85.7 Million

EUR as of July 1, 2024

US$92.0 Million

business BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Company Profile

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Main Stock Listing

FSX: 6NQ

Market Capitalization History of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €69.0 M -15.54%
Jan. 1, 2023 €81.7 M 39.36%
Jan. 1, 2022 €58.6 M -56.22%
Jan. 1, 2021 €133.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Categories

Poland languages Healthcare languages Biotechnology
Poland Healthcare Poland Biotechnology

Stocks & Indices

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA has the following listings and related stock indices.


Stock: FSX: 6NQ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.